Three-Year Outcomes After Sirolimus-Eluting Stent Implantation for Unprotected Left Main Coronary Artery Disease Insights From the j-Cypher Registry

被引:78
|
作者
Toyofuku, Mamoru [4 ]
Kimura, Takeshi [1 ]
Morimoto, Takeshi [2 ,3 ]
Hayashi, Yasuhiko [4 ]
Ueda, Hiroaki [4 ]
Kawai, Kazuya [8 ]
Nozaki, Yoichi [7 ]
Hiramatsu, Shinichi [6 ]
Miura, Akira [5 ]
Yokoi, Yoshiaki [13 ]
Toyoshima, Shinichiro [12 ]
Nakashima, Hitoshi [11 ]
Haze, Kazuo [10 ]
Tanaka, Masaru [9 ]
Take, Shunsuke [16 ]
Saito, Shigeru [15 ]
Isshiki, Takaaki [14 ]
Mitsudo, Kazuaki [17 ]
机构
[1] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Sakyo Ku, Kyoto 6068507, Japan
[2] Kyoto Univ, Grad Sch Med, Ctr Med Educ, Kyoto 6068507, Japan
[3] Kyoto Univ, Grad Sch Med, Clin Epidemiol Unit, Kyoto 6068507, Japan
[4] Tsuchiya Gen Hosp, Hiroshima, Japan
[5] Japanese Red Cross Soc Wakayama Med Ctr, Wakayama, Japan
[6] Ehime Prefectural Cent Hosp, Matsuyama, Ehime, Japan
[7] Hokko Mem Hosp, Sapporo, Hokkaido, Japan
[8] Chikamori Hosp, Kochi, Japan
[9] Osaka Red Cross Hosp, Osaka, Japan
[10] Osaka City Gen Hosp, Osaka, Japan
[11] Natl Hosp Org Kagoshima Med Ctr, Kagoshima, Japan
[12] Nanpuh Hosp, Kagoshima, Japan
[13] Kishiwada Tokushukai Hosp, Kishiwada, Japan
[14] Teikyo Univ Hosp, Tokyo, Japan
[15] Shonan Kamakura Gen Hosp, Kamakura, Kanagawa, Japan
[16] Saiseikai Noe Hosp, Osaka, Japan
[17] Kurashiki Cent Hosp, Kurashiki, Okayama, Japan
关键词
stents; revascularization; coronary disease; ischemia; restenosis; BYPASS-SURGERY; THROMBOSIS; STENOSIS; SURVIVAL;
D O I
10.1161/CIRCULATIONAHA.109.873349
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Long-term outcomes after stenting of an unprotected left main coronary artery (ULMCA) with drug-eluting stents have not been addressed adequately despite the growing popularity of this procedure. Methods and Results-j-Cypher is a multicenter prospective registry of consecutive patients undergoing sirolimus-eluting stent implantation in Japan. Among 12 824 patients enrolled in the j-Cypher registry, the unadjusted mortality rate at 3 years was significantly higher in patients with ULMCA stenting (n = 582) than in patients without ULMCA stenting (n = 12 242; 14.6% versus 9.2%, respectively; P < 0.0001); however, there was no significant difference between the 2 groups in the adjusted risk of death (hazard ratio 1.23, 95% confidence interval 0.95 to 1.60, P = 0.12). Among 476 patients whose ULMCA lesions were treated exclusively with a sirolimus-eluting stent, patients with ostial/shaft lesions (n = 96) compared with those with bifurcation lesions (n = 380) had a significantly lower rate of target-lesion revascularization for the ULMCA lesions (3.6% versus 17.1%, P = 0.005), with similar cardiac death rates at 3 years (9.8% versus 7.6%, P = 0.41). Among patients with bifurcation lesions, patients with stenting of both the main and side branches (n = 119) had significantly higher rates of cardiac death (12.2% versus 5.5%; P = 0.02) and target-lesion revascularization (30.9% versus 11.1%; P < 0.0001) than those with main-branch stenting alone (n = 261). Conclusions-The higher unadjusted mortality rate of patients undergoing ULMCA stenting with a sirolimus-eluting stent did not appear to be related to ULMCA treatment itself but rather to the patients' high-risk profile. Although long-term outcomes in patients with ostial/shaft ULMCA lesions were favorable, outcomes in patients with bifurcation lesions treated with stenting of both the main and side branches appeared unacceptable. (Circulation. 2009;120:1866-1874.)
引用
收藏
页码:1866 / U50
页数:16
相关论文
共 50 条
  • [31] Long-Term Outcome of Sirolimus-Eluting Stent Implantation for Left Main Coronary Artery Stenosis in Infancy
    Kaichi, Shinji
    Doi, Hiraku
    Tsurumi, Fumitoshi
    Heike, Toshio
    PEDIATRIC CARDIOLOGY, 2011, 32 (01) : 94 - 97
  • [32] Everolimus- versus sirolimus-eluting stents for the treatment of unprotected left main coronary artery stenosis (results from the EXCELLENT registry)
    Park, Kyung Woo
    Lim, Woo-Hyun
    Ahn, Hyo-Suk
    Kang, Si-Hyuck
    Han, Jung-Kyu
    Lee, Sang Eun
    Cho, Jang-Hyun
    Gwon, Hyeon-Cheol
    Lee, Sung Yoon
    Rhew, Jae-Young
    Kim, Wan
    Chae, In-Ho
    Kim, Hyo-Soo
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 168 (03) : 2738 - 2744
  • [33] Are Paclitaxel-Eluting Stents Better in Unprotected Left Main Coronary Artery Disease? Three-Year Clinical and Intravascular Imaging Results From a Randomized Study
    Narbute, Inga
    Jegere, Sanda
    Kumsars, Indulis
    Mintale, Iveta
    Zakke, Ilja
    Bumeistere, Kristine
    Sondore, Dace
    Grave, Alona
    Erglis, Andrejs
    MEDICINA-LITHUANIA, 2011, 47 (10): : 536 - 543
  • [34] Incidence and outcome of surgical procedures after sirolimuseluting stent implantation: a report from the j-Cypher registry
    Kimura, Takeshi
    Isshiki, Takaaki
    Hayashi, Yasuhiko
    Oshima, Shigeru
    Namura, Masanobu
    Nakashima, Hitoshi
    Kawai, Kazuya
    Sone, Takahito
    Tatami, Ryozo
    Meguro, Taiichiro
    Nobuyoshi, Masakiyo
    Mitsudo, Kazuaki
    CARDIOVASCULAR INTERVENTION AND THERAPEUTICS, 2010, 25 (01) : 29 - 39
  • [36] Age-based clinical and angiographic outcomes after sirolimus-eluting stent implantation in patients with coronary artery disease
    Xu Bo
    Li Jian-jun
    Yang Yue-jin
    Chen Ji-lin
    Qiao Shu-bin
    Qin Xue-wen
    Ma Wei-hua
    Yao Min
    Liu Hai-bo
    Wu Yong-jian
    Yuan Jin-qing
    Chen Jue
    You Shi-jie
    Dai Jun
    Xia Ran
    Gao Run-lin
    CHINESE MEDICAL JOURNAL, 2007, 120 (06) : 447 - 451
  • [37] Long-Term Outcomes of Sirolimus-Eluting Stents vs Paclitaxel-Eluting Stents in Unprotected Left Main Coronary Artery Bifurcation Lesions
    Song, Pil Sang
    Ryu, Dong Ryeol
    Song, Young Bin
    Hahn, Joo-Yong
    Choi, Jin-Ho
    Choi, Seung-Hyuk
    Lee, Sang Hoon
    Hong, Kyung Pyo
    Park, Jeong Euy
    Gwon, Hyeon-Cheol
    CLINICAL CARDIOLOGY, 2011, 34 (06) : 378 - 383
  • [38] Three-year clinical outcomes after coronary stenting of chronic total occlusion using sirolimus-eluting stents:: Insights from the rapamycin-eluting stent evaluated at Rotterdam Cardiology Hospital -: (RESEARCH) registry
    Garcia-Garcia, Hector M.
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2007, 70 (05) : 635 - 639
  • [39] Comparison of Outcomes Using the Sirolimus-Eluting Stent in Calcified Versus Non-Calcified Native Coronary Lesions in Patients On- Versus Not On-Chronic Hemodialysis (from the j-Cypher Registry)
    Nishida, Koji
    Kimura, Takeshi
    Kawai, Kazuya
    Miyano, Ichiro
    Nakaoka, Yoko
    Yamamoto, Satoshi
    Kaname, Noriyoshi
    Seki, Shuichi
    Kubokawa, Shoichi
    Fukatani, Masahiko
    Hamashige, Naohisa
    Morimoto, Takeshi
    Mitsudo, Kazuaki
    AMERICAN JOURNAL OF CARDIOLOGY, 2013, 112 (05) : 647 - 655
  • [40] Long-term clinical outcomes after a percutaneous coronary intervention with a drug-eluting stent in patients with unprotected left main coronary artery disease excluded from clinical trials
    Oh, Young Soo
    Lee, Hyun Jong
    Lee, Juneyoung
    Choi, Young Jin
    Choi, Rak Kyeung
    Yu, Cheol Woong
    Park, Jinsik
    Choi, Jin-Oh
    Kim, Je Sang
    Kim, Tae-Hoon
    Jang, Ho-Jun
    Park, Seung Woo
    Lee, Sang Hoon
    CORONARY ARTERY DISEASE, 2019, 30 (04) : 239 - 248